stars 1 stars 2 stars 3

SCINTIPHARMA, Inc. is a privately held company focused on problem solving in the field of pharmaceutical dosage form development. The company's main objective is to provide services to the pharmaceutical industry for the optimization of drug delivery systems. The primary mission is improved delivery of currently marketed and potentially marketable therapeutic agents in the gastrointestinal tract as well as other routes such as nasal, ocular, inhalation, or rectal. Some of the world's principal experts in pharmaceutical drug delivery are available for consultation. Scintipharma staff received their formal training from and continue to consult the innovating pioneer of gamma scintigraphy in pharmaceutical research. Pharmaceutical formulation and gamma scintigraphic studies have been performed for many of the pharmaceutical industries leading companies. For further information, contact: Scintipharma, Inc. Walter J. Doll, Ph.D. 1721 Maywick View Lane Lexington, Kentucky 40504 USA Tel: (859) 276-3320 Fax: (859) 276-3234 e-mail: wdoll@scintipharma.com [Home] [What is Gamma Scintigraphy? ] [Why use Gamma Scintigraphy? ] [About the InteliSite capsule ] [About Scintipharma ]

Scintipharma Inc Questions

The Scintipharma Inc annual revenue was $3 million in 2026.

Scintipharma Inc is based in Lexington, Kentucky.

The NAICS codes for Scintipharma Inc are [3254, 32, 325, 32541].

The SIC codes for Scintipharma Inc are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users